You are on page 1of 1

9/7/12

V accination P rogram for C ommercial Lay ers*

TABLE 18: Vaccination Program for Commercial Layers*

A ge

Vaccine

Route

Type

1 day 14 -21 days 14-21 days 5 wk 8-10 wk 10-12 wk 10-12 wk 10-12 wk 10-14 wk or 18 wk 12-14 wk 16-18 wk and every

Marek’s disease Infectious bursal disease

SC Water

Turkey herpesvirus and SB-1 B1/Mass Intermediate

Newcastle/infectious bronchitis Water

Newcastle/infectious bronchitis Water or coarse spray B1/Mass Newcastle/infectious bronchitis Water or coarse spray B1 or LaSota/Mass Encephalomyelitis Fowlpox Laryngotracheitis Mycoplasma gallisepticum M gallisepticum

Wing web Wing web Intraocular Intraocular or spray Parenteral

Live, chick-embryo origin Modified live Modified live Mild live strain Inactivated B1 or LaSota/Mass B1 or LaSota/Mass Inactivated

Newcastle/infectious bronchitis Water or aerosol Newcastle/infectious bronchitis Water or aerosol

60-90 days or 18 wk Newcastle/infectious bronchitis Parenteral

* This

is an e x am ple of a vaccination program . Individual program s are highly variable and re fle ct local conditions, dise ase pre vale nce , se ve rity of challe nge , and individual pre fe re nce s.
† The

use of M gallisepticum vaccine is re gulate d or prohibite d in som e state s. SB-1 or MDV301 m ay be com bine d with turk e y he rpe svirus in som e are as. Vaccination for infe ctious bursal dise ase , laryngotrache itis, and fowlpox de pe nds on local re quire m e nts. O the r strains of infe ctious bronchitis (C onne cticut, Ark ansas 99, Florida 88, e tc) are include d in som e are as. M gallisepticum and Haemophilus gallinarum (coryza) are use d only on infe cte d, m ultiage pre m ise s in som e are as.

© 2011; Me rck Sharp & Dohm e C orp., a subsidiary of Me rck & C o., Inc.W hite house Station, NJ USA. All R ights R e se rve d.

Disclaim e r / Fe e dback

w w w .merckv etmanual.com/mv m/htm/bc/tpou18.htm